AT-II-receptor antagonists include losartan, valsartan, irbesartan, candesartan, eprosartan, telmisartan, and tasosartan. Several clinical trials have demonstrated that AT-II-receptor antagonists ...

Cyclosporine-drug interactions in adult transplant patients and the impact of age were studied. The medical records of transplant patients receiving cyclosporine therapy were identified.

This resulted in additional recalls of Valsartan, and losartan-containing products found to contain NDMA and N-Nitrosodiethylamine (NDEA), known animal and suspected human carcinogens. In November ...

Additionally, they can be used to prevent aortic wall dilatation in collagenopathies (e.g., Marfan Syndrome). Losartan, Valsartan, Irbesartan, Olmesartan, and Candesartan are the most commonly used ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

When NDMA contamination was first discovered in valsartan in 2018, it triggered global recalls, regulatory pressure, and a ...

Dementia is the UK's biggest killer, claiming more lives than heart attacks and strokes combined. Despite exhaustive research ...

Invokana (canagliflozin) has potential interactions with alcohol, other medications, and some supplements. For example, Invokana can interact with lithium and other diabetes drugs. Invokana is ...

Arbli is supplied as an peppermint-flavored oral suspension containing 10mg/mL of losartan potassium in 165mL bottles. The Food and Drug Administration (FDA) has approved Arbli ™, an oral suspension ...